What is Morpheus8V used for?

Morpheus8V is offered to women who are experiencing concerns such as:

• Vaginal dryness or discomfort

• Pain during intercourse (dyspareunia)

• Mild urinary symptoms such as stress incontinence

• Changes in tissue laxity following childbirth or hormonal changes

It may also be considered where changes in vulvar tissue appearance are a concern. This is discussed carefully during consultation to ensure appropriateness and realistic expectations.

How it works

Morpheus8V combines microneedling with radiofrequency energy.

• Microneedles create controlled microchannels in tissue

• Radiofrequency energy is delivered into deeper layers

• This process is used to stimulate collagen and elastin remodelling responses over time

This is a controlled medical procedure and does not rely on surgical techniques.

Goals of treatment

Morpheus8V may be considered to support:

• Vaginal dryness and discomfort

• Sexual comfort and sensation

• Mild urinary symptoms

• Changes in tissue laxity

In some cases, it may also be used in relation to external vulvar tissue texture or appearance, depending on clinical suitability.

Consultation – Morpheus8V

Your consultation with Dr Jess Tucker is a medical assessment focused on your symptoms, medical history, and treatment goals.

You will receive a balanced discussion of:

• Whether this treatment may be appropriate for you

• Expected variability in individual response

• Risks, limitations, and uncertainties

• Alternative treatment options where relevant

All care is individualised.

Procedure overview

• A topical numbing cream is applied for comfort

• A specialised device delivers microneedling and radiofrequency energy into targeted tissue

• Treatment is applied internally and externally depending on clinical indication

The procedure is generally well tolerated.

Treatment time

Each session typically lasts 30–60 minutes.

Recovery

Mild post-treatment effects such as redness, swelling, or tenderness may occur and typically resolve over several days.

Most patients can resume normal daily activities shortly after treatment. Timing for resuming sexual activity is discussed individually based on treatment intensity.

Outcomes and expectations

Morpheus8V is used to support collagen and elastin remodelling responses within treated tissue over time.

Some patients report changes in symptoms such as comfort, sensitivity, or tissue tightness in the weeks to months following treatment. However, responses vary between individuals and outcomes cannot be guaranteed.

Improvements, where they occur, are typically gradual and associated with a course of treatments.

Treatment course

While some individuals may notice changes after a single session, a course of treatments is often recommended.

• Typically 2–3 sessions

• Spaced approximately 4–6 weeks apart

• Maintenance treatments may be considered depending on individual response

Clinical positioning

Morpheus8V is not presented as a first-line treatment for sexual dysfunction or urinary symptoms.

It is offered selectively following consultation as part of a broader treatment approach. Alternative options will be discussed where appropriate.

The V Clinic approach

• Private, doctor-led consultations

• Evidence-informed clinical decision-making

• Individualised treatment planning

• Emphasis on safety, discretion, and comfort

Combination treatments

Morpheus8V may be combined with VTone, FormaV, or V-PRP Intimate Health Therapy where clinically appropriate.

Suitability is determined during consultation.

Please contact us to discuss Morpheus8V or book an initial consultation online.